Clinical significance of serum Ykl-40 (chitinase-3-like-1 protein) as a biomarker in melanoma: An analysis of 112 Turkish patients
Asian Pacific Journal of Cancer Prevention, cilt.18, sa.5, ss.1383-1387, 2017 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 18 Sayı: 5
- Basım Tarihi: 2017
- Doi Numarası: 10.22034/apjcp.2017.18.5.1383
- Dergi Adı: Asian Pacific Journal of Cancer Prevention
- Derginin Tarandığı İndeksler: Scopus
- Sayfa Sayıları: ss.1383-1387
- Anahtar Kelimeler: Biomarkers, CHI3L1, Diagnostic, Melanoma, Prognostic, YKL-40
- Sağlık Bilimleri Üniversitesi Adresli: Hayır
Özet
Background: Angiogenesis plays an essential role in tumor growth and serum levels of YKL-40, a strong angiogenic factor that promotes tumor vessel development, has been found to be elevated in various cancers. We here investigated correlation between melanoma parameters and serum YKL-40 levels, to assess potential diagnostic, prognostic and predictive values. Material and Methods: Data for 112 pathologically confirmed cutaneous melanomas of any stage were examined retrospectively. ELISA assays were used to measure serum YKL-40 in plasma samples. Results: The baseline serum YKL-40 levels were significantly higher in patients than healthy controls (174.88 vs 120.10 ng/mL, p < 0.001). However, values did not correlate with clinicopathological parameters, (p > 0.05), and furthermore there was no apparent prognostic influence on melanoma survival (HR: 1.568; 95% CI, 0.580-3.051; p=0.838). Conclusion: Serum YKL-40 can be useful for diagnosis of melanoma, but reliability in assessing prognosis is questionable. We believe that efforts should be made to understand the interaction between YKL-40 and the tumor environment, and establish whether it might be the target for treatment of malignancies.